Ex parte DI ZEREGA - Page 2


                    Appeal No. 1996-1934                                                                                                  
                    Application 07/884,218                                                                                                




                            Claims 1, 22 and 23 are illustrative of the subject matter on appeal and are                                  
                    reproduced below:                                                                                                     
                            1.      A method for introduction of medicaments to and retaining said                                        
                    medicament in the peritoneal cavity of a mammal undergoing surgery which                                              
                    comprises providing to the peritoneal cavity a solution of a medicament to combat                                     
                    interperitoneal infection and a hyaluronic acid compound selected from hyaluronic                                     
                    acid and water-soluble salts thereof in a sterile isotonic, flowable, pharmaceutically                                
                    acceptable media in which the hyaluronic acid compound is present in a                                                
                    concentration of at least about 0.4% by weight based on the weight of the solution,                                   
                    said solution having a viscosity at 25"C of from about 500 to about 10,000                                            
                    centipoise, said hyaluronic acid compound serving to retain said medicament in the                                    
                    peritoneal cavity.                                                                                                    
                            22.     A method for combating infections of the peritoneal cavity which                                      
                    comprises providing to the peritoneal cavity of a mammal undergoing surgery, a                                        
                    solution of a medicament and an hyaluronic acid compound selected from                                                
                    hyaluronic acid and water-soluble salts thereof in a sterile, isotonic, flowable                                      
                    pharmaceutically acceptable media in which the hyaluronic acid compound is                                            
                    present in a concentration of at least about 0.4% by weight based on the weight of                                    
                    the solution, said solution having a viscosity at 25"C of from about 500 to about                                     
                    10,000 centipoise, said hyaluronic acid compound acting to retain the inroduced                                       
                    medicament in the peritoneal cavity, the amount of solution applied being in an                                       
                    amount sufficient to at least coat traumatized tissue and up to an amount sufficient                                  
                    to coat the peritoneal cavity, said solution being applied to the peritoneal cavity                                   
                    during the period from beginning of surgery up to closure at conclusion of surgery.                                   
                            23.     A method as claimed in claim 22 in which the solution is applied as a                                 
                    single application at closing of the peritoneal cavity at the end of the operative                                    
                    procedure.                                                                                                            
                            The references relied upon by the examiner are:                                                               
                    Della Valle et al.                         4,736,024                              Apr.  5, 1988                       
                    (Della Valle)                                                                                                         
                    Goldberg et al.                           5,080,893                              Jan. 14, 1992                        
                    (Goldberg)                                                                                                            

                                                     GROUND OF REJECTION                                                                  

                                                                    2                                                                     



Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007